Monday November 23 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Oxford GlycoSciences plc

OGS' drug discovery and development business has grown through our industrial proteomics technology experience coupled with our investment in core areas of research excellence such as glycobiology and glycochemistry.



Based on this combination of platform and drug discovery and development expertise and complemented by key alliances with high-profile companies, OGS has built ambitious programmes to discover new drugs in the areas of cancer, infectious disease and glycolipid storage disorders (GLSDs). By implementing our 'platform to product' vision, we believe our pipeline is poised for expansion in 2002 and beyond.


Contact Details:
10 The Quadrant Barton Lane
Abingdon
Oxfordshire
OX14 3YS
United Kingdom
Tel:44 1235 543200
Fax:44 1235 554701
Email:info@ogs.co.uk
WWW:

www.ogs.com/




Loading...

Press Releases on Oxford GlycoSciences plc:

BioPortfolio Logo
Oxford Genome Sciences appoints Jeff Warren to the Board of Directors 1st June, 2005 Oxford Genome Sciences
Oxford Genome Sciences appoints Jeff Warren to the Board of Directors Oxford, UK, 8 June 2005 - Oxford Genome Sciences (UK) Ltd (OGeS) today announced the appointment of Jeff Warren as
SENEXIS APPOINTS CHRIS MOYSES AS CHAIRMAN AND DAVID SCOPES AS CHIEF 1st November, 2004 Senexis
SENEXIS APPOINTS CHRIS MOYSES AS CHAIRMAN AND DAVID SCOPES AS CHIEF SCIENTIFIC OFFICER Cambridge, UK, November 2004.  Senexis Limited announced today the appointment of
Bayer Healthcare Diagnostics and Oxford Genome Sciences Partner in 1st August, 2004 Oxford Genome Sciences
Bayer Healthcare Diagnostics and Oxford Genome Sciences Partner in Proteomics-based Evaluation of New Biomarkers for Breast Cancer Oxford, UK, 16 March, 2005 - Oxford Genome
Oxford Genome Sciences closes financing and moves to state-of-the-art 1st July, 2004 Oxford Genome Sciences
Oxford Genome Sciences closes financing and moves to state-of-the-art proteomics facility Oxford, UK, 4th April 2005 - Oxford Genome Sciences (UK) Ltd (OGeS), the proteomics

Oxford GlycoSciences plc (OGSI) Financial information Links from Barchart

OGSI Quote from from Barchart.com
OGSI Chart from from Barchart.com
OGSI Profile from from Barchart.com
OGSI Opinion from from Barchart.com

View more Oxford GlycoSciences plc finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 408 times since April 2007, the link to the organisation's website has been followed 119 times

Recent Search Terms used to find this page: 29 The Quadrant Barton Lane | Oxford glycoscience PLC | oxford glycosciences quote | Oxford Glycosciences Plc | .

Search for more companies in Abingdon

Search for more companies in Oxfordshire



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Oxford GlycoSciences plc

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.